bf/NASDAQ:CCRN_icon.jpeg

NASDAQ:CCRN

Cross Country Healthcare, Inc.

  • Stock

USD

Last Close

13.04

06/11 21:00

Market Cap

449.63M

Beta: 0.98

Volume Today

175.56K

Avg: 645.90K

PE Ratio

6.94

PFCF: 3.09

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
6.12M
-
5.30M
13.42%
5.32M
0.50%
5.71M
7.19%
5.75M
0.72%
6.15M
7.05%
5.78M
6.12%
6.55M
13.43%
9.36M
42.83%
5.53M
40.87%
average payables
18.79M
-
34.21M
82.01%
49.97M
46.08%
54.72M
9.51%
47.17M
13.79%
44.73M
5.16%
47.80M
6.85%
79.81M
66.97%
147.63M
84.97%
92.75M
37.17%
average receivables
93.99M
-
134.40M
42.99%
163.20M
21.43%
176.88M
8.38%
173.71M
1.79%
172.43M
0.74%
174.62M
1.27%
336.83M
92.89%
579.46M
72.03%
516.16M
10.92%
book value per share
4.16
-
4.47
7.33%
4.71
5.32%
6.77
43.84%
6.10
9.89%
4.54
25.57%
4.28
5.80%
8.11
89.57%
12.35
52.33%
13.34
8.02%
capex per share
-0.15
-
-0.07
48.86%
-0.20
170.81%
-0.15
28.09%
-0.13
11.67%
-0.08
36.33%
-0.13
55.79%
-0.20
52.82%
-0.24
21.47%
-0.39
65.93%
capex to depreciation
-0.61
-
-0.29
52.33%
-0.71
142.56%
-0.50
29.28%
-0.39
22.32%
-0.21
46.47%
-0.36
74.37%
-0.73
99.82%
-0.70
4.00%
-0.76
9.02%
capex to operating cash flow
1.12
-
-0.13
111.54%
-0.22
67.03%
-0.11
48.09%
-0.22
94.94%
-0.53
142.31%
-0.17
68.02%
0.08
149.36%
-0.07
178.27%
-0.06
14.20%
capex to revenue
-0.01
-
-0.00
58.40%
-0.01
154.22%
-0.01
24.49%
-0.01
4.71%
-0.00
36.49%
-0.01
54.31%
-0.00
22.50%
-0.00
26.80%
cash per share
0.16
-
0.08
51.40%
0.64
724.84%
0.73
13.58%
0.45
38.40%
0.03
93.59%
0.04
53.87%
0.03
36.31%
0.10
244.84%
0.48
394.84%
days of inventory on hand
4.82
-
2.89
39.93%
3.65
26.26%
3.03
17.04%
3.73
23.14%
3.60
3.58%
3.14
12.71%
2.14
31.75%
1.85
13.56%
days payables outstanding
21.67
-
26.31
21.42%
35.10
33.39%
29.02
17.34%
26.31
9.34%
27.00
2.62%
28.73
6.42%
30.78
7.13%
31.08
0.97%
days sales outstanding
70.34
-
71.22
1.25%
77.36
8.62%
74.73
3.40%
76.14
1.89%
77.48
1.77%
76.24
1.61%
108.62
42.48%
85.83
20.98%
debt to assets
0.23
-
0.25
7.75%
0.22
8.73%
0.21
5.40%
0.19
8.10%
0.25
27.44%
0.20
17.45%
0.27
30.18%
0.17
37.61%
0.01
95.34%
debt to equity
0.57
-
0.64
11.88%
0.58
9.83%
0.42
27.33%
0.38
8.55%
0.58
52.64%
0.47
18.81%
0.66
38.66%
0.35
47.49%
0.01
96.78%
dividend yield
0.00
-
earnings yield
-0.08
-
0.01
110.48%
0.02
85.70%
0.08
428.55%
-0.06
177.25%
-0.13
107.27%
-0.04
71.78%
0.13
441.68%
0.19
47.86%
0.09
52.81%
enterprise value
458.33M
-
603.94M
31.77%
567.97M
5.95%
520.43M
8.37%
328.53M
36.87%
510.06M
55.26%
391.65M
23.21%
1.21B
209.70%
1.14B
6.21%
791.35M
30.43%
enterprise value over ebitda
27.26
-
16.59
39.12%
13.48
18.78%
12.60
6.51%
11.04
12.36%
23.06
108.84%
13.67
40.71%
7.56
44.72%
3.73
50.62%
6.12
63.95%
ev to operating cash flow
-112.56
-
33.12
129.42%
18.84
43.11%
11.44
39.30%
15.65
36.82%
92.04
488.22%
14.40
84.36%
-14.17
198.40%
8.49
159.90%
3.18
62.47%
ev to sales
0.74
-
0.79
6.08%
0.68
13.41%
0.60
11.71%
0.40
33.12%
0.62
54.17%
0.47
24.52%
0.72
54.50%
0.41
43.97%
free cash flow per share
-0.28
-
0.50
281.76%
0.74
45.96%
1.15
56.91%
0.46
60.13%
0.07
84.20%
0.63
761.57%
-2.53
504.04%
3.38
233.82%
6.61
95.33%
free cash flow yield
-0.02
-
0.03
238.40%
0.05
53.26%
0.09
91.96%
0.06
30.60%
0.01
90.04%
0.07
1,028.69%
-0.09
229.10%
0.13
239.82%
0.29
129.24%
graham net net
-3.13
-
-3.42
9.39%
-2.50
26.82%
-1.97
21.29%
-1.74
11.78%
-2.34
34.82%
-1.85
21.08%
-1.53
17.12%
0.36
123.79%
2.55
599.53%
graham number
9.77
-
3.75
61.57%
5.12
36.48%
12.77
149.29%
8.08
36.77%
12.63
56.39%
5.69
54.95%
25.62
350.24%
37.62
46.83%
24.79
34.10%
income quality
0.13
-
3.68
2,750.50%
3.45
6.20%
1.17
66.03%
-1.34
213.91%
-0.10
92.58%
-2.24
2,161.63%
-0.65
71.05%
0.71
209.66%
3.42
381.01%
intangibles to total assets
0.50
-
0.49
2.82%
0.39
19.57%
0.44
12.23%
0.41
5.75%
0.40
3.96%
0.37
7.17%
0.23
37.94%
0.22
4.13%
0.28
27.39%
interest coverage
-2.52
-
3.02
220.01%
1.01
66.46%
2.79
175.27%
-2.28
181.71%
1.52
166.54%
5.53
264.59%
20.29
267.11%
18.98
6.46%
13.93
26.62%
interest debt per share
2.51
-
3.07
22.31%
2.90
5.53%
2.95
1.83%
2.49
15.59%
2.80
12.33%
2.11
24.71%
5.52
161.75%
4.65
15.67%
0.38
91.90%
inventory turnover
75.75
-
126.09
66.46%
99.87
20.80%
120.38
20.54%
97.76
18.79%
101.40
3.72%
116.17
14.57%
170.20
46.51%
196.88
15.68%
invested capital
0.57
-
0.64
11.88%
0.58
9.83%
0.42
27.33%
0.38
8.55%
0.58
52.64%
0.47
18.81%
0.66
38.66%
0.35
47.49%
0.01
96.78%
market cap
389.25M
-
516.51M
32.69%
501.58M
2.89%
446.83M
10.92%
261.37M
41.51%
416.17M
59.23%
320.10M
23.08%
1.02B
218.18%
983.41M
3.44%
803.18M
18.33%
net current asset value
-63.62M
-
-66.01M
3.76%
-30.96M
53.09%
-21.08M
31.92%
-13.90M
34.06%
-35.52M
155.52%
-18.95M
46.64%
72.99M
485.12%
185.05M
153.53%
209.23M
13.06%
net debt to ebitda
4.11
-
2.40
41.53%
1.58
34.41%
1.78
13.10%
2.26
26.70%
4.24
88.05%
2.50
41.15%
1.21
51.49%
0.51
58.27%
-0.09
118.08%
net income per share
-1.02
-
0.14
113.76%
0.25
76.86%
1.07
332.05%
-0.48
144.38%
-1.56
228.57%
-0.34
78.46%
3.60
1,169.34%
5.09
41.53%
2.05
59.79%
operating cash flow per share
-0.13
-
0.58
543.21%
0.94
62.13%
1.30
38.52%
0.59
54.69%
0.15
73.72%
0.75
387.16%
-2.33
409.57%
3.62
255.20%
7.00
93.40%
payables turnover
16.84
-
13.87
17.64%
10.40
25.03%
12.58
20.97%
13.87
10.30%
13.52
2.55%
12.70
6.03%
11.86
6.65%
11.75
0.96%
receivables turnover
5.19
-
5.13
1.24%
4.72
7.93%
4.88
3.52%
4.79
1.85%
4.71
1.73%
4.79
1.63%
3.36
29.81%
4.25
26.55%
research and ddevelopement to revenue
return on tangible assets
-0.20
-
0.02
112.01%
0.03
43.42%
0.14
324.33%
-0.07
147.36%
-0.24
258.54%
-0.05
77.80%
0.23
533.49%
0.25
9.04%
0.15
41.74%
revenue per share
19.81
-
24.35
22.94%
25.94
6.53%
24.70
4.77%
22.90
7.31%
22.96
0.26%
23.18
0.96%
45.70
97.17%
75.83
65.93%
roe
-0.24
-
0.03
112.82%
0.05
67.94%
0.16
200.37%
-0.08
149.25%
-0.34
341.43%
-0.08
77.13%
0.44
664.08%
0.41
7.09%
0.15
62.78%
roic
-0.05
-
0.11
305.39%
0.05
53.03%
0.32
532.24%
-0.04
111.74%
0.07
278.43%
0.06
3.65%
0.27
327.24%
0.32
18.42%
0.16
48.91%
sales general and administrative to revenue
0.23
-
0.21
7.93%
0.22
2.65%
0.22
0.44%
0.22
1.88%
shareholders equity per share
4.16
-
4.47
7.33%
4.71
5.32%
6.77
43.84%
6.10
9.89%
4.54
25.57%
4.28
5.80%
8.11
89.57%
12.35
52.33%
13.34
8.02%
stock based compensation to revenue
0.00
-
0.00
42.79%
0.00
26.46%
0.00
16.35%
0.00
7.17%
0.00
5.67%
0.01
56.40%
0.00
36.35%
0.00
35.94%
tangible asset value
-32.34M
-
-36.67M
13.38%
-83K
99.77%
32.45M
39,198.80%
41.55M
28.05%
11.58M
72.14%
23.25M
100.86%
129.79M
458.16%
249.23M
92.02%
283.50M
13.75%
tangible book value per share
-1.04
-
-1.16
12.21%
-0.00
99.78%
0.93
35,976.48%
1.17
25.75%
0.32
72.26%
0.64
99.34%
3.54
449.01%
6.73
90.34%
7.99
18.67%
working capital
64.19M
-
72.70M
13.26%
108.52M
49.27%
114.30M
5.33%
109.52M
4.18%
97.89M
10.62%
89.69M
8.38%
308.50M
243.97%
404.03M
30.97%
266.57M
34.02%

All numbers in USD (except ratios and percentages)